Adjuvant chemotherapy for radically resected non-small cell lung cancer: A retrospective analysis of 311 consecutively treated patients

Lung Cancer

Volumn 47, Issue 1, 2005, Pages 93-101

  Dediu, Mircea ^a,c   Horvat, Teodor ^b   Tarlea, Alin ^a   Anghel, Rodica ^a   Cordos, Ioan ^b   Miron, Geanina ^a   Iorga, Polixenia ^a   Alexandru, Aurelia ^a   Nistor, Claudiu ^b   Grozavu, Constantin ^b   Savu, Cornel ^b  

^a Institutul Oncologic Prof Dr Alexandru Trestioreanu Bucuresti   (Romania)

^b Central Military Hospital Bucharest   (Romania)

^c 8 Ap 34 Sector 2 Str Doamna G ^*  (Romania)

Author keywords

Non small cell lung cancer; Postoperative chemotherapy; Survival

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; NAVELBINE; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 10444231110     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.06.008     Document Type: Article

References (32)

1. C. Mountain International staging system for lung cancer H. Pass J. Mitchell D. Johnson A. Turrisi J. Minna Lung Cancer second ed. 2000 Lippincott Wiliams & Wilkins Philadelphia 591 601
2. P. Souquet, and L. Geriniere The role of chemotherapy in early stage non-small cell lung cancer Lung Cancer 34 2001 S155 S158
3. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small cell lung cancer: systematic review and meta-analysis of individual data from nine randomized controlled trials Lancet 352 1998 257 263
4. Non Small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials Br Med J 311 1995 899 909
5. B. Passlick Micrometastases in non-small cell lung cancer (NSCLC) Lung Cancer 34 Suppl. 3 2001 S25 S29
6. R. Rossell, E. Felip, and J. Maestre The role of chemotherapy in early non-small-cell lung cancer management Lung Cancer 34 Suppl. 3 2001 S63 S74
7. G. Scagliotti, and S. Novello The dream is almost over...don't worry, look ahead Lung Cancer 40 2003 187 190
8. Web site: http//www.spss.com.
9. M. Dediu Controversies in the management of non-small cell lung cancer: chemotherapy around surgery; pre or post-operative? J BUON 8 2003 97 100
10. M. Kris, and C. Azzoli Chemotherapy for early stage non-small cell lung cancer Lung Cancer 34 Suppl. 3 2001 S49 S52
11. R. Feld, L. Rubinstein, and P.A. Thomas Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected Stage I non-small cell lung cancer J Natl Cancer Inst 85 1993 299 306
12. M. Ohta, M. Fukuoka, and R. Tsuchiya Adjuvant chemotherapy for completely resected Stage III non-small cell lung cancer J Thorac Cardiovasc Surg 106 1993 703 708
13. S.M. Keller, S. Adak, and H. Wagner A randomized trial of postoperative adjuvant therapy in patients with completely resected Stage II or III A non-small cell lung cancer N Engl J Med 343 2000 1217 1222
14. M. Tonato on behalf of the ALPI/EORTC-LCCG investigators. Initial report of the Adjuvant Lung Project Italy (ALPI): an Italian /EORTC-LCCG randomized trial of adjuvant chemotherapy in completely resected non-small cell lung cancer Proc. Am Soc Clin Oncol. 21 2002 290a (abstract 1157)
15. H. Tada, R. Tsuchiya, and Y. Ichinose A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304) Lung Cancer 43 2004 167 173
16. A. Niiranen, S. Niitamo-Korhonen, and M. Kouri Adjuvant chemotherapy after radical surgery for non-small cell lung cancer: a randomized study J Clin Oncol 10 1992 1927 1932
17. H. Wada, S. Hitomi, and T. Teramatsu Adjuvant chemotherapy after complete resection in non-small cell lung cancer J Clin Oncol 14 1996 1048 1054
18. H. Kato, M. Tsuboi, and Ohta A randomized phase III trial of adjuvant chemotherapy for completely resected pathological Stage I (T1N0M0) adenocarcinoma of the lung Proc Am Soc Clin Oncol 22 2003 621 (abstract 2498)
19. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 2004; 350: 351-60.
20. R. Ginsberg, and J. Port Surgical therapy of Stage I and non-T3N0 Stage II non-small cell lung cancer H. Pass J. Mitchell D. Johnson A. Turrisi J. Minna Lung Cancer second ed. 2000 Lippincott Wiliams & Wilkins Philadelphia 682 693
21. S. Lee, E. Choi, and W. Chung Postoperative adjuvant chemotherapy and radiotherapy for Stage II and III non-small cell lung cancer (NSCLC) Lung Cancer 37 2002 65 71
22. C.F. Mountain, J.M. Lukeman, S.P. Hammar and the Lung Cancer Study Group Pathology Committee Lung Cancer Classification: the relationship of disease extent and cell type survival in a clinical trial population J Surg Oncol 35 1987 147 157
23. P. Fumoleau, A. Bremond, P. Kerbrat for the French Adjuvant Study Group Better outcome of premenopausal node-positive (N+) breast cancer treated with 6 cycles vs. 3 cycles of adjuvant chemotherapy: eight year follow up results of FASG 01 Proc Am Soc Clin Oncol. 18 1999 67a (abstract 252)
24. Burdette-Radoux S, Muss H. The role of antracyclines in adjuvant chemotherapy for breast cancer. In: Perry MC (Ed.), American Society of Clinical Oncology Educational Book 2003. Alexandria, 2003. p. 53-57.
25. M. Piccart, F. Cardoso, and A. Di Leo Areas of controversy in the adjuvant systemic therapy of endocrine non-responsive breast cancer M.C. Perry American Society of Clinical Oncology Educational Book 2002 2002 Lippincott Williams & Wilkins Baltimore 144 155
26. Foster R. Testis cancer update management options for clinical Stage I non-seminoma and post-chemotherapy retroperitoneal lymph node dissection. In: Perry MC, (Ed.), American Society of Clinical Oncology 2003 Educational Book. Alexandria, 2003. p. 136-142.
27. C. Henderson, D. Berry, and G. Demetri Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer J Clin Oncol 21 2003 976 983
28. C. Lohrish, and M. Piccart Standard medical treatment for early breast cancer Eur J Cancer 37 Suppl. 7 2001 45 58
29. G. Lyman, D. Dale, and J. Crawford Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices J Clin Oncol 21 2003 4524 4531
30. H. Raftopoulos, R.J. Gralla, and G. D'Auria Assessing the role of cisplatin dose and dose-intensity (DI) in advanced non-small cell lung cancer (NSCLC): a comprehensive review of randomized trials 1992-2002 Proc Am Soc Clin Oncol 22 2003 645a (abstract 2596)
31. D. Ball Prophylactic cranial irradiation in small cell lung cancer H. Pass J. Mitchell D. Johnson A. Turrisi J. Minna Lung Cancer second ed. 2000 Lippincott Wiliams & Wilkins Philadelphia 981 992
32. M. Stuschke, W. Eberhardt, and C. Pottgen Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects J Clin Oncol 17 1999 2700 2710